Finance

Second quarter net loss: $0.20 per share

Published in Blood Weekly, September 12th, 2002

Corvas International, Inc., (CVAS) reported financial results for the second quarter of 2002, which were in line with management's expectations.

Second quarter operating revenues of $46,000 and operating expenses of $6.2 million contributed to a net loss of $5.5 million, or $0.20 per share. In the second quarter of 2001, operating revenues of $94,000 and operating expenses of $11.1 million contributed to a net loss of $9.6 million, or $0.35 per share.

Cash, cash equivalents, and investments at June 30, 2002, totaled $101.4 million, compared with $112.3 million at December 31, 2001. These investments mature at various dates through May 17, 2004. As...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-09-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry